Literature DB >> 28947719

Clinical and genetic characterization of six cases with complete androgen insensitivity syndrome in China.

Jing He1, Shuwu Qi, Huijun Zhang, Jingjing Guo, Shu Chen, Qi Zhang, Baosheng Zhu.   

Abstract

Themutations of androgen receptor (AR) gene are the most common cause for complete androgen insensitivity syndrome (CAIS). We aimed to characterize the six cases enrolled in our hospital (the First People's Hospital of Yunnan, China) and explore the molecular mechanism of CAIS. Between 2010 and 2013, six female cases were enrolled in our hospital for the agenesis of secondary sexual characteristics. The clinical examinations such as sex hormone test and B ultrasound were performed and the genetic characterization of patients were evaluated by karyotype analysis, polymerase chain reaction and DNA sequencing. The six cases with 46, XY karyotype were diagnosed with CAIS and four novel AR mutations were discovered, which were responsible for Chinese CAIS. The molecular study of the AR gene facilitated the understanding of themechanism of CAIS and provided the genetic counselling clinically.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28947719     DOI: 10.1007/s12041-017-0809-4

Source DB:  PubMed          Journal:  J Genet        ISSN: 0022-1333            Impact factor:   1.166


  18 in total

1.  The syndrome of testicular feminization in male pseudohermaphrodites.

Authors:  J M MORRIS
Journal:  Am J Obstet Gynecol       Date:  1953-06       Impact factor: 8.661

2.  Complete androgen insensitivity syndrome characterized by increased concentration of a normal androgen receptor in genital skin fibroblasts.

Authors:  I A Hughes; B A Evans
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

3.  Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations.

Authors:  Alberto Ferlin; Cinzia Vinanzi; Andrea Garolla; Riccardo Selice; Daniela Zuccarello; Carla Cazzadore; Carlo Foresta
Journal:  Clin Endocrinol (Oxf)       Date:  2006-11       Impact factor: 3.478

4.  Novel and recurrent mutations in patients with androgen insensitivity syndromes.

Authors:  Susanne Ledig; Sibylle Jakubiczka; Joseph Neulen; Ute Aulepp; Uta Burck-Lehmann; Klaus Mohnike; Hannelore Thiele; Hannelore Zierler; Carole Brewer; Peter Wieacker
Journal:  Horm Res       Date:  2005-05-26

5.  The androgen receptor gene mutations database: 2012 update.

Authors:  Bruce Gottlieb; Lenore K Beitel; Abbesha Nadarajah; Miltiadis Paliouras; Mark Trifiro
Journal:  Hum Mutat       Date:  2012-03-13       Impact factor: 4.878

6.  Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome.

Authors:  Sabine E Hannema; Ian S Scott; John Hodapp; Howard Martin; Nick Coleman; John W Schwabe; Ieuan A Hughes
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

7.  Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome.

Authors:  S F Ahmed; A Cheng; L Dovey; J R Hawkins; H Martin; J Rowland; N Shimura; A D Tait; I A Hughes
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

Review 8.  Androgen insensitivity syndrome: clinical features and molecular defects.

Authors:  Angeliki Galani; Sophia Kitsiou-Tzeli; Christalena Sofokleous; Emmanuel Kanavakis; Ariadni Kalpini-Mavrou
Journal:  Hormones (Athens)       Date:  2008 Jul-Sep       Impact factor: 2.885

9.  Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility.

Authors:  D Zuccarello; A Ferlin; C Vinanzi; E Prana; A Garolla; L Callewaert; F Claessens; A O Brinkmann; C Foresta
Journal:  Clin Endocrinol (Oxf)       Date:  2007-10-29       Impact factor: 3.478

10.  Androgen receptor gene mutation, rearrangement, polymorphism.

Authors:  Kurtis Eisermann; Dan Wang; Yifeng Jing; Laura E Pascal; Zhou Wang
Journal:  Transl Androl Urol       Date:  2013-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.